Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Fate Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 Jul 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Fate Therapeutics Inc (FATE-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Jul 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for FATE

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

24 Jul 2016 ValuEngine, Inc. 11 $25.00

FATE THERAPEUTICS INC (FATE=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Jul 2016 Pechala's Reports 2 $25.00

Value Graph: FATE THERAPEUTIC -- FATE

22 Jul 2016 Ford Investor Services, Inc. 1 $12.00

Fate Therapeutics, Inc. (FATE) - Financial Analysis Review

Fate Therapeutics, Inc. (FATE) - Financial Analysis Review Summary Fate Therapeutics, Inc. (Fate Therapeutics) is a biopharma...

18 Jul 2016 GlobalData 54 $300.00

Wright Investors Service Comprehensive Report for Fate Therapeutics Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

24 Jun 2016 Wright Reports 59 $75.00

Fate Therapeutics, Inc. (FATE) - Financial Analysis Review

Fate Therapeutics, Inc. (FATE) - Financial Analysis Review Summary Fate Therapeutics, Inc. (Fate Therapeutics) is a biopharma...

17 Jun 2016 GlobalData 53 $300.00

Thomson Reuters Stock Report - Fate Therapeutics Inc (FATE-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00

Fate Therapeutics, Inc. (FATE) - Financial Analysis Review

Fate Therapeutics, Inc. (FATE) - Financial Analysis Review Summary Fate Therapeutics, Inc. (Fate Therapeutics) is a bio-pharm...

17 Mar 2016 GlobalData 54 $300.00